Clinical trial

Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+

NCT01174914

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-03-01

PhasePHASE2

Study timeline

Study start (unknown)2008-03-01Date precision: month

Registry last updated2010-08-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Seropositivityunresolved

Interventions

ARV's + PlaceboOTHER

NaltrexoneDRUG · verified · RxNorm: naltrexone

Naltrexone + ARV'sDRUG

Sponsors & collaborators

The Ojai Foundationlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01174914 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.